Detalhe da pesquisa
1.
Novel insight into atogepant mechanisms of action in migraine prevention.
Brain;
2024 Feb 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38411458
2.
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
Headache;
64(5): 469-481, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38706199
3.
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
J Headache Pain;
25(1): 83, 2024 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38773375
4.
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials.
J Headache Pain;
25(1): 35, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38462625
5.
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Cephalalgia;
51(8): 3331024231190296, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37638400
6.
Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysis.
Headache;
63(8): 1135-1144, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37655536
7.
Phase Ib, open-label, fixed-sequence, drug-drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine.
Headache;
63(3): 322-332, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36602199
8.
Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
Headache;
63(10): 1448-1457, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37795746
9.
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
Cephalalgia;
42(1): 3-11, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34521260
10.
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open;
5(6): e2215499, 2022 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35675076